La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Accolade Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Raj Singh

Amministratore delegato

US$3.8m

Compenso totale

Percentuale dello stipendio del CEO	13.1%
Mandato del CEO	9yrs
Proprietà del CEO	1.0%
Durata media del management	3.6yrs
Durata media del Consiglio di amministrazione	5.2yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Raj Singh rispetto agli utili di Accolade?
Data	Compenso totale	Stipendio	Guadagni aziendali
May 31 2024	n/a	n/a	-US$89m
Feb 29 2024	US$4m	US$500k	-US$100m
Nov 30 2023	n/a	n/a	-US$123m
Aug 31 2023	n/a	n/a	-US$142m
May 31 2023	n/a	n/a	-US$155m
Feb 28 2023	US$2m	US$500k	-US$460m
Nov 30 2022	n/a	n/a	-US$464m
Aug 31 2022	n/a	n/a	-US$401m
May 31 2022	n/a	n/a	-US$417m
Feb 28 2022	US$6m	US$471k	-US$123m
Nov 30 2021	n/a	n/a	-US$93m
Aug 31 2021	n/a	n/a	-US$132m
May 31 2021	n/a	n/a	-US$85m
Feb 28 2021	US$3m	US$400k	-US$51m
Nov 30 2020	n/a	n/a	-US$48m
Aug 31 2020	n/a	n/a	-US$50m
May 31 2020	n/a	n/a	-US$49m
Feb 29 2020	US$3m	US$394k	-US$51m
Nov 30 2019	n/a	n/a	-US$56m
Feb 28 2019	US$574k	US$350k	-US$56m

Compensazione vs Mercato: La retribuzione totale di Raj ($USD 3.82M ) è superiore alla media delle aziende di dimensioni simili nel mercato German ($USD 1.10M ).

Compensazione vs guadagni: La retribuzione di Raj è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Raj Singh (56 yo)

9yrs

Mandato

US$3,823,597

Compensazione

Mr. Rajeev Singh, also known as Raj, serves as Director at Amperity, Inc. He has been the Chief Executive Officer and Executive Director of Accolade, Inc. since October 2015 and also serves as its Chairman...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Rajeev Singh	Chairman of the Board & CEO	9yrs	US$3.82m	0.99% $ 2.7m
Robert Cavanaugh	President	5.8yrs	US$1.79m	0.24% $ 668.3k
Stephen Barnes	CFO & Treasurer	9.7yrs	US$1.78m	0.25% $ 688.1k
Richard Eskew	Executive VP	6.5yrs	US$1.02m	0.064% $ 173.9k
Kristen Bruzek	Senior Vice President of Operations	1.5yrs	Nessun dato	Nessun dato
Colin McHugh	Chief Accounting Officer	1.3yrs	Nessun dato	0.067% $ 182.3k
Todd Friedman	Senior Vice President of Investor Relations	4yrs	Nessun dato	Nessun dato
Kelsi McDonald Harris	Chief People Officer & Senior Vice President	less than a year	Nessun dato	Nessun dato
Drew Garner	Executive Vice President of Engineering	2.8yrs	Nessun dato	Nessun dato
Shantanu Nundy	Executive VP	4.8yrs	Nessun dato	Nessun dato
James Wantuck	Senior VP & Chief Medical Officer - Care	1.1yrs	Nessun dato	Nessun dato
Ryan McQuaid	Executive Vice President & Chief Product Officer	3.2yrs	Nessun dato	Nessun dato

3.6yrs

Durata media

53yo

Età media

Gestione esperta: Il team dirigenziale di 4NE1 è considerato esperto (durata media dell'incarico 3.4 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Rajeev Singh	Chairman of the Board & CEO	9yrs	US$3.82m	0.99% $ 2.7m
Shantanu Nundy	Executive VP	5.8yrs	Nessun dato	Nessun dato
Dawn Lepore	Independent Director	5.3yrs	US$237.00k	0% $ 0
Jeffrey Jordan	Independent Director	8.3yrs	US$222.00k	0.035% $ 94.9k
Michael Hilton	Director	1.7yrs	Nessun dato	0.43% $ 1.2m
Patricia Wadors	Independent Director	4.7yrs	US$222.00k	0.035% $ 94.9k
Peter Klein	Lead Independent Director	5.1yrs	US$262.00k	0.035% $ 96.8k
Larry Kaiser	Member of Medical Advisory Board	no data	Nessun dato	Nessun dato
Jeffrey Brodsky	Independent Director	3.3yrs	US$226.41k	0.053% $ 145.0k
Joseph Betancourt	Member of Medical Advisory Board	no data	Nessun dato	Nessun dato
Saul Weiner	Member of Medical Advisory Board	no data	Nessun dato	Nessun dato
Jennifer Lerner	Member of Medical Advisory Board	no data	Nessun dato	Nessun dato

5.2yrs

Durata media

60.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 4NE1 sono considerati esperti (durata media dell'incarico 5 anni).

Accolade Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Accolade, Inc., Annual General Meeting, Aug 06, 2024

Accolade, Inc. Promotes Kelsi McDonald Harris to Chief People Officer and Senior Vice President

Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience

Accolade, Inc., Annual General Meeting, Aug 08, 2023

Accolade, Inc. Announces Changes to Its Board of Directors

Chairman of the Board & CEO recently bought €173k worth of stock

Recent updates

Accolade, Inc. to Report Q2, 2025 Results on Oct 08, 2024

First quarter 2025 earnings released: US$0.35 loss per share (vs US$0.53 loss in 1Q 2024)

Accolade, Inc., Annual General Meeting, Aug 06, 2024

Accolade, Inc. to Report Q1, 2025 Results on Jun 27, 2024

Full year 2024 earnings released: US$1.33 loss per share (vs US$6.45 loss in FY 2023)

Accolade, Inc. to Report Q4, 2024 Results on Apr 25, 2024

Accolade, Inc. Promotes Kelsi McDonald Harris to Chief People Officer and Senior Vice President

Third quarter 2024 earnings released: US$0.28 loss per share (vs US$0.56 loss in 3Q 2023)

Accolade, Inc. Provides Earnings Guidance for the Fourth Quarter and Year Ending February 29, 2024 and Year Ending February 28, 2025

Accolade, Inc. to Report Q3, 2024 Results on Jan 08, 2024

Second quarter 2024 earnings released: US$0.43 loss per share (vs US$0.66 loss in 2Q 2023)

Accolade, Inc. to Report Q2, 2024 Results on Oct 04, 2023

Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience

First quarter 2024 earnings released: US$0.53 loss per share (vs US$4.92 loss in 1Q 2023)

Accolade, Inc., Annual General Meeting, Aug 08, 2023

Accolade, Inc. to Report Q1, 2024 Results on Jun 29, 2023

Full year 2023 earnings released: US$6.45 loss per share (vs US$1.93 loss in FY 2022)

Accolade, Inc. Announces Changes to Its Board of Directors

Third quarter 2023 earnings released: US$0.56 loss per share (vs US$0.34 profit in 3Q 2022)

Accolade, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending February 28, 2023; Provides Earnings Guidance for the Year Ending February 29, 2024

Accolade, Inc. to Report Q3, 2023 Results on Jan 09, 2023

Second quarter 2023 earnings released: US$0.66 loss per share (vs US$0.97 loss in 2Q 2022)

Accolade, Inc. Provides Revenue Guidance for the Fiscal Third Quarter Ending November 30, 2022 and Fiscal Year Ending February 28, 2023

Accolade, Inc. to Report Q2, 2023 Results on Oct 06, 2022

Chairman of the Board & CEO recently bought €173k worth of stock

Accolade, Inc. Appoints Kelli Burns as Senior Vice President, Chief Information Security Officer

Accolade, Inc. Provides Earnings Guidance for Second Quarter Ending August 31, 2022 and Fiscal Year Ending February 28, 2023

Accolade, Inc.(NasdaqGS:ACCD) dropped from Russell 2000 Growth Index

Accolade, Inc., Annual General Meeting, Jul 26, 2022

Accolade, Inc. to Report Q1, 2023 Results on Jun 30, 2022

Accolade, Inc. announced delayed annual 10-K filing

Full year 2022 earnings released: US$1.93 loss per share (vs US$1.73 loss in FY 2021)

Accolade, Inc. to Report Q4, 2022 Results on Apr 28, 2022

Accolade, Inc. Provides Earnings Guidance for the Fourth Quarter, Fiscal Year Ending February 28, 2022 and Fiscal Year 2023

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Second quarter 2022 earnings released: US$0.97 loss per share (vs US$0.47 loss in 2Q 2021)

Accolade Introduces Personalized Healthcare Category

High number of new directors

High number of new directors

First quarter 2022 earnings released: US$0.84 loss per share (vs US$1.86 loss in 1Q 2021)

Accolade, Inc.(NasdaqGS:ACCD) dropped from Russell 2500 Value Index

Accolade, Inc. (NasdaqGS:ACCD) completed the acquisition of PlushCare, Inc.

Independent Chairman J. Cline has left the company

Independent Director William Frist has left the company

Full year 2021 earnings released: US$1.73 loss per share (vs US$9.13 loss in FY 2020)

Accolade, Inc. Provides Earnings Guidance for the First Quarter Ending May 31, 2021 and Fiscal Year Ending February 28, 2022

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media